Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 3—March 2009

Dispatch

Hepatitis E Virus Antibodies in Patients with Chronic Liver Disease

Muslim Atiq, Norah J. Shire, Anna Barrett, Susan D. Rouster, Kenneth E. Sherman, and Mohamed T. ShataComments to Author 
Author affiliations: University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA (M. Atiq); University of Cincinnati College of Medicine, Cincinnati, Ohio, USA (N.J. Shire, A. Barrett, S.D. Rouster, K.E. Sherman, M.T. Shata)

Main Article

Figure 1

Relationship between anti-hepatitis E virus (HEV) immunoglobulin (Ig) G and chronic liver disease. Scattered plot of the optical density (OD) of anti-HEV IgG for both liver disease patients and control groups is shown; each point represents a subject. Means (0.63 and 0.13 for patients with chronic liver disease and for control group, respectively) are plotted as horizontal lines.

Figure 1. Relationship between anti-hepatitis E virus (HEV) immunoglobulin (Ig) G and chronic liver disease. Scattered plot of the optical density (OD) of anti-HEV IgG for both liver disease patients and control groups is shown; each point represents a subject. Means (0.63 and 0.13 for patients with chronic liver disease and for control group, respectively) are plotted as horizontal lines.

Main Article

TOP